Show simple item record

dc.contributor.authorHirvonen, O. Petteri
dc.contributor.authorKyröläinen, Heikki
dc.contributor.authorLehti, Maarit
dc.contributor.authorKainulainen, Heikki
dc.date.accessioned2021-11-10T11:03:20Z
dc.date.available2021-11-10T11:03:20Z
dc.date.issued2021
dc.identifier.citationHirvonen, O. P., Kyröläinen, H., Lehti, M., & Kainulainen, H. (2021). Randomized Trial : D-Glyceric Acid Activates Mitochondrial Metabolism in 50–60-Year-Old Healthy Humans. <i>Frontiers in Aging</i>, <i>2</i>, Article 752636. <a href="https://doi.org/10.3389/fragi.2021.752636" target="_blank">https://doi.org/10.3389/fragi.2021.752636</a>
dc.identifier.otherCONVID_101832823
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/78580
dc.description.abstractBackground: Based on earlier studies, natural metabolite D-glyceric acid (DGA) does not seem to play any role in whole-body metabolism. Nevertheless, one ethanol oxidation-related rat study with controversial results raised our interest. According to preparatory studies for the regulatory approval of DGA, some highly conserved mechanism seems to subtly activate the cellular energy metabolism. Therefore, the present 25-days double-blind human study with placebo control was initiated. Purpose: The main target in the present study with 27 healthy 50–60-year-old human volunteers was to find out whether an “acute” 4-days and a longer 21-days exogenous DGA regimen caused moderate activation of the mitochondrial energy metabolism. The simultaneous target was to find out whether a halved dose of DGA continued to be an effective regimen. Main Findings: The results revealed the following statistically significant findings: 1) plasma concentrations of metabolites related to aerobic energy production, especially lactate, were strongly reduced, 2) systemic inflammation was lowered both in 4- and 21-days, 3) mitochondria-related mRNA expressions in circulating immune cells were noticeably modulated at Day4, 4) cellular membrane integrity seemed to be sharply enhanced, and 5) cellular NADH/NAD+ -ratio was upregulated. Conclusion: Mitochondrial metabolism was clearly upregulated at the whole-body level in both 4- and 21 days. At the same time, the effect of DGA was very well tolerated. Based on received solid results, the DGA regimen may alleviate acute and chronic energy metabolic challenges in main organs like the liver, CNS, and skeletal muscles. Enhanced membrane integrity combined with lower systemic inflammation and activated metabolic flows by the DGA regimen may be beneficial especially for the aging population.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherFrontiers Media SA
dc.relation.ispartofseriesFrontiers in Aging
dc.rightsCC BY 4.0
dc.subject.otherD-glyseriinihappo
dc.subject.othermitochondrial activation
dc.subject.otherre-oxidation
dc.subject.othermembrane integrity
dc.subject.othersubclinical inflammation
dc.subject.otherDGA activation
dc.titleRandomized Trial : D-Glyceric Acid Activates Mitochondrial Metabolism in 50–60-Year-Old Healthy Humans
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202111105599
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.contributor.oppiaineLiikuntafysiologiafi
dc.contributor.oppiaineExercise Physiologyen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn2673-6217
dc.relation.volume2
dc.type.versionpublishedVersion
dc.rights.copyright© 2021 Hirvonen, Kyröläinen, Lehti and Kainulainen.
dc.rights.accesslevelopenAccessfi
dc.subject.ysoenergiankulutus (aineenvaihdunta)
dc.subject.ysoaineenvaihdunta
dc.subject.ysosolut
dc.subject.ysotulehdus
dc.subject.ysosatunnaistetut vertailukokeet
dc.subject.ysomitokondriot
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p24540
jyx.subject.urihttp://www.yso.fi/onto/yso/p3066
jyx.subject.urihttp://www.yso.fi/onto/yso/p2409
jyx.subject.urihttp://www.yso.fi/onto/yso/p1049
jyx.subject.urihttp://www.yso.fi/onto/yso/p38295
jyx.subject.urihttp://www.yso.fi/onto/yso/p21158
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.3389/fragi.2021.752636
jyx.fundinginformationUniversity of Jyväskylä (JyU) provided the study site and equipment without cost. Replicon Health Oy paid salary for the corresponding author.
dc.type.okmA1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY 4.0
Except where otherwise noted, this item's license is described as CC BY 4.0